Browsing by Author "González Bergas, Fermín"

Now showing items 1-4 of 4

    • Development of ethical practices and social responsibility in dental education at the university of Chile: ... 
      Alcota Rojas, Marcela; Ruiz de Gauna, P.; González Bergas, Fermín (2013)
      Background: The authors argue that dental curricula in Latin America are noted for providing highly technical and individualistic training that may fail to address society’s problems or instil in the dentist the idea ...
    • Host-pathogen interactions in progressive chronic periodontitis 
      Hernández Ríos, Emma; Dutzan Muñoz, Nicolás; García Sesnich, Jocelyn; Abusleme Ramos, Loreto Andrea; Dezerega Piwonka, Andrea; Silva Steffens, Nora; González Bergas, Fermín; Vernal Astudillo, Rolando; Sorsa, T.; Gamonal Aravena, Jorge Antonio (Sage, 2011-10)
      Periodontitis is an infection characterized by the occurrence of supporting tissue destruction with an episodic nature. Disease progression is often determined by the loss of attachment level or alveolar bone, and sequential ...
    • Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma ... 
      González Bergas, Fermín; Ramírez Fernández, Marcos; Allerbring, Eva B.; Fasching, Nina; Lundqvist, Andreas; Poschkee, Isabel; Achour, Adnane; Salazar Onfray, Flavio (Elsevier, 2013-10-12)
      Background: Melanocortin 1 Receptor (MC1R) is expressed in a majority of melanoma biopsies and cell lines. We previously demonstrated that three hydrophobic low-affinity HLA-A2-restricted MC1R-derived peptides: MC1R291–298, ...
    • Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic ... 
      González Bergas, Fermín; Ortiz, Carolina; Reyes Rojas, Montserrat; Dutzan Muñoz, Nicolás; Patel, Vyomesh; Pereda, Cristián; Gleisner Muñoz, María Alejandra; López Nitsche, Mercedes; Gutkind, J. Silvio; Salazar Onfray, Flavio (John Wiley & Sons Ltd,, 2014)
      We have previously reported a novel method for the production of tumour-antigen-presenting cells (referred to as TAPCells) that are currently being used in cancer therapy, using an allogeneic melanomaderived cell lysate ...